EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction

Marius Messemaker, Bjørn P Y Kwee, Živa Moravec, Sam de Paauw, Jos Urbanus, Daniel Álvarez-Salmoral, Jeroen Geerligs, Ren Xie, Rhianne Voogd, Ben Morris, Aurélie Guislain, Yaël Winkler und 11 weitere

Immunity · 2026-10 · 59 (10) · 2775-2788.e9

DOI: 10.1016/j.immuni.2026.09.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, 2026-10. Verfasst von Marius Messemaker und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands. Hauptthemen laut MEDLINE: Receptors, Antigen, T-Cell, Major Histocompatibility Complex, Histocompatibility Antigens. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Netherlands Organisation for Health Research and Development, Louis-Jeantet Foundation, KWF Dutch Cancer Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate prediction of T cell receptor (TCR) reactivity is a long-standing goal in immunology. Here, we asked whether functional validation of TCR-peptide-major histocompatibility complex (MHC) (TCR-pMHC) pairs at scale alters performance estimates of TCR-pMHC reactivity prediction models. We developed a TCR rapid assembly platform (T-RAP) that allowed the generation of large and uniform TCR libraries. T-RAP enabled evaluation of TCR signaling or MHC multimer binding of thousands of previously reported TCR-pMHC pairs under standardized conditions. In this setting of systematic standardized evaluation, only ∼50% of these TCRs showed the previously reported TCR reactivity. Notably, AlphaFold3 structural predictions showed good performance in identifying reactive TCR-pMHC pairs within the set of TCRs that experimentally validated without any task-specific training. AlphaFold3 structural predictions could likewise be used to shortlist TCRs reactive to patient-specific cancer neoantigens. In silico prediction of TCR-pMHC reactivity thus has greater feasibility than previously assumed, with implications for basic research and clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Antigen, T-CellMajor Histocompatibility ComplexHistocompatibility AntigensHumansComputer SimulationImmunoinformaticsProtein BindingPeptidesSignal TransductionAnimals

Stichwörter der Autor:innen

T cell receptorTCR assemblyTCR specificity modelsTCR-pMHC reactivity modelsepitopehigh-throughput functional screeningmajor histocompatibility antigenpeptide MHCpooled genetic screeningvalidation

Substanzen

Receptors, Antigen, T-CellPeptidesHistocompatibility Antigens

Autor:innen und Institutionen

  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands.
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Oncode Institute, Utrecht, the Netherlands; Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; The NKI Robotics and Screening Center, The Netherlands Cancer Instit…
  • The NKI Robotics and Screening Center, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • AI for Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Förderung

  • Netherlands Organisation for Health Research and Development
  • Louis-Jeantet Foundation
  • KWF Dutch Cancer Society
  • Cancer Research UK
  • National Institutes of Health National Cancer Institute
  • The Mark Foundation for Cancer Research
  • Oncode Institute Foundation

Zitieren

APA

Messemaker, M., Kwee, B. P. Y., Moravec, Ž., de Paauw, S., Urbanus, J., Álvarez-Salmoral, D., Geerligs, J., Xie, R., Voogd, R., Morris, B., Guislain, A., Winkler, Y., Richterich, C. A., Mussmann, M., Bakker, M., Steinmetz, M., Iras, M., Marcus, E., Teuwen, J., …, & Schumacher, T. N. (2026). Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction. Immunity, 59(10), 2775-2788.e9. https://doi.org/10.1016/j.immuni.2026.09.007

Vancouver

Messemaker M, Kwee BPY, Moravec Ž, de Paauw S, Urbanus J, Álvarez-Salmoral D, et al. Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction. Immunity. 2026;59(10):2775-2788.e9. doi:10.1016/j.immuni.2026.09.007

BibTeX
@article{Messemaker2026,
  author = {Messemaker, Marius and Kwee, Bjørn P Y and Moravec, Živa and de Paauw, Sam and Urbanus, Jos and Álvarez-Salmoral, Daniel and Geerligs, Jeroen and Xie, Ren and Voogd, Rhianne and Morris, Ben and Guislain, Aurélie and Winkler, Yaël and Richterich, Connor A and Mussmann, Maike and Bakker, Marijn and Steinmetz, Maxime and Iras, Matyas and Marcus, Eric and Teuwen, Jonas and Perrakis, Anastassis and Beijersbergen, Roderick L and Scheper, Wouter and Schumacher, Ton N},
  title = {Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction},
  journal = {Immunity},
  year = {2026},
  volume = {59},
  number = {10},
  pages = {2775--2788.e9},
  doi = {10.1016/j.immuni.2026.09.007}
}
Kostenlos starten →